Moderate Evidence
Research Overview
Cerebrolysin Research for Traumatic Brain Injury
An evidence-based overview of research examining Cerebrolysin in the context of traumatic brain injury. This page synthesizes findings from peer-reviewed literature.
Research Summary
Cerebrolysin is used for traumatic brain injury in multiple countries. Preclinical studies show enhanced neurogenesis and angiogenesis in the ischemic penumbra. Clinical trials have shown improved outcomes, though large definitive trials are limited.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Traumatic Brain Injury
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Cerebrolysin may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.